UK markets closed

Biodesix, Inc. (BDSX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4000+0.0900 (+6.87%)
At close: 04:00PM EDT
1.4000 0.00 (0.00%)
After hours: 04:04PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-52,146
-52,146
-65,447
-43,159
-31,350
Depreciation & amortisation
5,507
5,507
5,844
3,178
2,903
Stock-based compensation
5,373
5,373
5,961
4,944
3,709
Change in working capital
-7,019
-7,019
-6,815
4,591
-4,801
Accounts receivable
-4,718
-4,718
-1,501
11,454
-10,308
Other working capital
-45,932
-45,932
-48,506
-30,770
-23,543
Other non-cash items
23,600
23,600
8,414
4,328
6,625
Net cash provided by operating activities
-22,870
-22,870
-44,972
-28,223
-21,366
Cash flows from investing activities
Investments in property, plant and equipment
-23,062
-23,062
-3,534
-2,547
-2,177
Acquisitions, net
-
-
-
0
-750
Net cash used for investing activities
-23,062
-23,062
-3,534
-2,547
-2,927
Cash flows from financing activities
Debt repayment
-49
-49
-28,604
-45,428
0
Common stock issued
28,126
28,126
59,538
16,343
72,000
Other financing activities
-9,682
-9,682
-17,778
-828
-8,249
Net cash used provided by (used for) financing activities
29,129
29,129
58,882
1,262
81,131
Net change in cash
-16,803
-16,803
10,376
-29,508
56,838
Cash at beginning of period
43,174
43,174
32,798
62,306
5,468
Cash at end of period
26,371
26,371
43,174
32,798
62,306
Free cash flow
Operating cash flow
-22,870
-22,870
-44,972
-28,223
-21,366
Capital expenditure
-23,062
-23,062
-3,534
-2,547
-2,177
Free cash flow
-45,932
-45,932
-48,506
-30,770
-23,543